Jamu: The 1,200-Year Industry Nobody Mapped

The paradox runs deeper than regulation. Virtually every major jamu company in Indonesia was founded by a Peranakan Chinese-Indonesian woman — a cross-cultural pattern that produced an entire industry between 1910 and 1951, and has no parallel anywhere in global traditional medicine. Their family dynasties still control the largest companies. And for the first time in the sector’s modern history, that founding generation is stepping aside.

The women who built an industry

I will be the last third-generation CEO.

The word jamu evolved from jampi — a Surakarta Palace court term for healing prayer. When botanical knowledge spread beyond the palace walls, linguistic hierarchy demanded the more common term. The knowledge itself is older: Borobudur Temple reliefs from the 8th century depict herbal preparation, and a Mataram Kingdom medicine book documents three thousand recipes.

But jamu as an industry — rather than a practice — begins in 1910, when Tan Swan Nio and Siem Tjiong Nio established the first commercial jamu company in Surabaya. Eight years later, in the hill town of Wonogiri, Tjia Kiat Nio — known as Mak Jago — and her husband pioneered the powdered jamu sachet. It was a manufacturing revolution disguised as a packaging decision: by reducing liquid herbal preparations to shelf-stable powder, they made jamu distributable across an archipelago of seventeen thousand islands.

In Semarang, Lauw Ping Nio launched her own company in 1919, using her portrait as a brand guarantee — a radical act for a Chinese-Indonesian woman in colonial Java. And in 1951, Go Djing Nio and her husband formalized their Semarang jamu business into what would become the sector’s dominant enterprise.

Four women. Four companies. All Peranakan Chinese-Indonesian — members of a community that occupied a particular position in colonial and post-colonial Java: commercially active but politically marginal, literate in both Chinese and Javanese traditions, trusted enough by Javanese households to enter them as healers but excluded from the kinds of institutional power that might have led them into other industries. The Peranakan women who built jamu were not rebels or eccentrics. They were pragmatists operating within the narrow commercial space available to them, deploying botanical knowledge that Javanese court culture had refined for centuries through the commercial networks that Chinese-Indonesian families had maintained for generations.

The one notable exception to the Peranakan founding pattern was a Surakarta palace princess who started selling traditional remedies from her garage in 1975, drawing on the same court manuscripts that had preserved jamu knowledge for centuries. Where the Peranakan founders brought commercial infrastructure to Javanese knowledge, she brought royal legitimacy — a different form of the same cross-cultural synthesis.

The pattern is globally unique. Indian Ayurveda was commercialized primarily by male-led family conglomerates. Korean ginseng was industrialized through government-led programs. Chinese traditional medicine scaled through state pharmaceutical enterprises. Only in Indonesia did a marginalized minority community’s women create the commercial foundation of a national heritage industry — and only in Indonesia have their family dynasties maintained control into the fourth generation. The hypothesis that pharmaceutical conglomerates had consolidated the sector proves largely wrong: only two of the eleven legacy brands were absorbed by larger groups. The family dynasties held.

Where turmeric becomes medicine

The heartland stretches across Central Java. A corridor running from Semarang through Solo to Sukoharjo concentrates the sector’s deepest history, largest producers, and most complete supply chain infrastructure. Sukoharjo was officially designated Kabupaten Jamu — Jamu Regency — in 2015, and its Nguter District has functioned as a jamu trading hub since 1965, with an entire village economy organized around what amounts to a commodities exchange for herbal ingredients. In 1995, entire villages from Nguter migrated to Jakarta in a phenomenon called bedol desa, seeding the capital’s street-vendor jamu network.

East Java provides the second cluster. Surabaya and Sidoarjo anchor a production zone built around the sector’s oldest company — now in its fourth generation, with a network of herbal bars that reimagined how Indonesians consume traditional remedies. The surrounding agricultural hinterland supplies raw materials, and port logistics enable what limited export activity exists.

Jakarta serves a different function entirely. The capital is where the new jamu movement lives — a post-2013 wave of entrepreneurs who applied specialty coffee techniques to traditional formulations. Pour-over jamu. French press turmeric. Jamu mocktails in co-working spaces frequented by Jakarta’s creative class. The aesthetic is third-wave coffee, but the ingredients are the same ones that Borobudur’s stone carvers depicted twelve centuries ago. The movement is real but early-stage — comparable to specialty coffee circa 2015, before venture capital redefined the category. No jamu startup has attracted Series A funding yet. What they have proven is the format: that Indonesian consumers under forty will pay premium prices for traditional remedies served in modern settings.

Yogyakarta anchors the cultural and academic dimension. The Sultan’s Palace — the Kraton — is the custodian of classical jamu manuscripts, and the word jamu itself evolved from the court vocabulary preserved within its walls. A nearby government research center supports standardization and clinical validation, the kind of institutional infrastructure that Korea used to build ginseng into a global brand but that Indonesia has barely begun to develop for jamu.

And then there is the diaspora. In New York, one Indonesian-American founder built a premium skincare line from Javanese court recipes, creating the only jamu-inspired beauty brand in the American market. In the Netherlands, a third-generation Moluccan-Dutch entrepreneur sells carbonated turmeric sodas through organic grocery chains, reclaiming ancestral heritage for a diaspora community three hundred thousand strong. These brands prove that jamu can command international pricing — but they also underscore how far the domestic industry is from systematic export.

What the databases miss

Indonesia’s jamu sector is invisible to institutional capital for reasons that compound on each other.

The language barrier is the most immediate. Over sixty percent of substantive source material — founder interviews, corporate profiles, industry analysis, regulatory documentation — exists only in Bahasa Indonesia. The richest features about the sector’s most important founders have been published in Kontan, Bisnis.com, and Tirto — publications that no English-language analyst reads. The crisis stories, the succession histories, the factory closures — all documented, all inaccessible across the language divide.

The statistical barrier is structural. Indonesia has no unified “jamu export” category. Finished herbal products scatter across multiple HS classifications — medicinal plants, pharmaceutical preparations, cosmetic botanicals — making it impossible to derive a clean export figure from trade databases. India created a dedicated Ministry of AYUSH with a substantial annual budget to promote Ayurveda globally. Korea built government-backed research infrastructure around ginseng standardization. Indonesia has no equivalent machinery for jamu.

The reputation barrier is self-inflicted. Between 2022 and 2023, the country’s food and drug authority discovered approximately one million articles of traditional medicines containing banned pharmaceutical chemicals — paracetamol, sildenafil, dexamethasone hidden in herbal products. In August 2023, five tons of adulterated jamu bound for export were intercepted. International regulators took notice: the US FDA issued public warnings against specific Indonesian herbal products. Singapore’s health authority and Saudi Arabia’s food and drug authority flagged products from the same category. For institutional investors assessing the sector from outside, the contamination headlines crowd out the heritage — even though the major registered producers have not been implicated.

And the analytical barrier is categorical. PitchBook, Crunchbase, Bloomberg — none of these platforms carry profiles for family-led Indonesian jamu companies. The private ones do not disclose revenue. The listed ones trade on the Indonesia Stock Exchange, covered by domestic analysts writing in Indonesian. The sector exists in the gap between local knowledge and institutional visibility.

The intelligence exists. It has not been assembled.

Those who built during the crisis

What separates the surviving jamu dynasties from those that failed is not market timing or product innovation. It is what founders did when continuing was irrational.

In 1972, a second-generation heir inherited a jamu company carrying thirty months of unpayable debt. Assets were at risk of state seizure. Rather than liquidate, he launched a women’s health product and advertised on two Jakarta FM radio stations. Sales covered the debt in month two, doubled it in month three. All obligations were repaid within six months. Twenty-five years later, the same man faced the Asian Financial Crisis. His response was to double his factory construction budget — from fifteen billion to thirty billion rupiah — and build a pharmaceutical-grade production facility while every competitor retrenched. The contrarian bet created the manufacturing infrastructure that would underpin four decades of market dominance. Today his company commands over forty percent of the Indonesian jamu market and generates revenues that place it among the country’s most profitable consumer enterprises. He has publicly stated he will be the last of his generation to lead.

The cautionary tale is equally specific. In 1919, a Peranakan woman in Semarang founded what would become one of Indonesia’s most iconic jamu brands. Her company survived Dutch colonialism, Japanese occupation, and Indonesian independence. It could not survive its own family. When her son died in 1976 followed by the founder herself in 1978, five grandchildren inherited control with no succession plan. A sixteen-year power struggle grew severe enough to require intervention by Indonesia’s Labor Minister. The grandson who eventually consolidated ownership could not reverse the financial decline. In 2017, the Semarang Commercial Court declared the company bankrupt — liabilities exceeding a quarter of a trillion rupiah. The brand’s seventy-two trademarks, appraised at two hundred billion rupiah, sold at auction for roughly ten billion. As of 2026, at least four separate entities claim rights to the name through overlapping lawsuits. A century of heritage, destroyed by the absence of a single document: a succession plan.

Between these poles — the contrarian builder and the succession catastrophe — the sector’s other dynasties are making their own choices. A Surakarta palace princess who founded her company at forty-two built it into a publicly listed enterprise with eight hundred products before dying at ninety-six in April 2024. She had installed a professional CEO before her death. Whether the transition holds is an open question. A former beverage executive reimagined jamu by applying coffee-brewing techniques — V60 pour-overs, French press infusions — to traditional formulations. He was simultaneously elected chairman of the national jamu trade association, holding the dual role of industry disruptor and institutional leader. His brand is eight years old. The dynasties he is trying to modernize have lasted a century.

Could Euromonitor have written any of this? It can name brands and cite production volumes. It cannot document the thirty months of unpayable debt, the decision to double the factory budget during a financial crisis, or the sixteen years of succession litigation that destroyed a heritage brand. That specificity — the named crisis, the named decision, the stated outcome — is intelligence that does not exist in any database.

More than medicine

Jamu operates on a hot-cold balance philosophy inherited from centuries of Hindu-Buddhist exchange: curing hot diseases with cold medicines and vice versa, with health defined as equilibrium between elements. But jamu diverges from both Ayurveda and Traditional Chinese Medicine through Indonesia’s extraordinary endemic biodiversity — over thirty thousand medicinal plant species, including plants beyond the Wallace Line found nowhere else on earth — and through the integration of animistic spiritual practices. Traditional acaraki — professional herbalists, a profession named in Majapahit-era inscriptions — fasted and meditated before preparing their formulations.

The gender dimension is equally distinctive. UNESCO’s inscription specifically recognizes jamu as women’s knowledge, transmitted from mother to daughter across generations. The iconic Mbok Jamu — a woman in kain kebaya carrying bottled remedies in a bamboo basket on her back — remains the living symbol of the tradition. In Sukoharjo’s Nguter District, the jamu economy is still overwhelmingly female: women who learned formulations from their mothers and grandmothers, operating micro-enterprises that collectively sustain an entire regency’s economy.

The Peranakan founding pattern at the industry’s commercial core mirrors this cultural reality. An industry built by women, certified by UNESCO as women’s heritage, now facing succession questions that will determine whether that heritage survives in corporate form. The new jamu movement has continued the pattern: several of the most prominent modern founders are women — a social enterprise co-founder who won one of the world’s most prestigious women’s entrepreneurship awards, a doctor who placed her jamu tisanes in five-star hotel channels, a Solo artisan who built a cultural preservation practice around jamu workshops. The gender lineage is unbroken.

The window that is closing

Three forces are converging on Indonesia’s jamu sector within the same eighteen-month period.

The regulatory cliff arrives in October 2026. Mandatory halal certification — phased in since 2019 for large companies — extends to small and medium enterprises in food and beverage. For a sector where eighty-seven percent of producers are micro and small enterprises, the compliance cost is existential. Indonesia’s halal certification body processes roughly one million certificates per year against an estimated sixty million MSMEs requiring them — a structural bottleneck that guarantees some producers will miss the deadline regardless of intent. The trade association has already confirmed that approximately four hundred factories closed between 2014 and 2019 from earlier, less demanding regulatory requirements. The halal deadline will accelerate that consolidation dramatically. Brands that survive with certification, BPOM compliance, and UNESCO cultural validation will command structural advantages that latecomers cannot replicate. Those that don’t will join the four hundred factories that have already disappeared.

The generational transition is simultaneous — and unprecedented. The sector’s dominant company has scheduled a shareholders’ meeting for April 2026 to potentially approve the handover from third to fourth generation leadership. The patriarch — who inherited unpayable debts and built the factory during the crisis — has publicly stated he will be the last of his generation to lead. At the sector’s oldest company, now one hundred and sixteen years old, a fourth-generation director manages the modernization of a heritage brand through a network of herbal bars. The sector’s most celebrated jamu-beauty founder died in April 2024, and the family’s ability to maintain control of a publicly listed company through professional management is an open question. Multiple other heritage houses operate under third and fourth-generation leadership with varying degrees of documented succession planning. The Nyonya Meneer bankruptcy stands as a warning to all of them: a century of heritage destroyed by the absence of a single document.

The validation catalyst has already arrived. UNESCO’s December 2023 inscription of jamu as Intangible Cultural Heritage provides exactly the kind of institutional legitimacy that transforms investor perception — the same legitimacy that Korea leveraged to build ginseng into a billion-dollar global brand, backed by dedicated research infrastructure and government export machinery. COVID-19’s demand surge in 2020 — when the president publicly shared his jamu recipe on Instagram and registration applications for immunity products surged by over a hundred percent — proved that crisis creates demand for exactly what jamu provides. And active deal flow — with the sector’s largest company exploring strategic options at a valuation that attracted Bloomberg’s attention, and a major competitor valued at half a billion dollars — demonstrates that capital is already moving, however quietly. The question is not whether the sector will attract institutional attention. The question is whether the intelligence to evaluate it will exist when that attention arrives.

The intelligence and the window

For an investor watching from Hong Kong, a family office in Dubai, or a strategic acquirer in Singapore, the question is not whether Indonesia’s jamu sector contains valuable assets. The sector’s own deal flow answers that question. The question is whether the intelligence infrastructure exists to evaluate those assets before the succession window closes — before the generational handover is complete, the regulatory consolidation reshapes the competitive landscape, and the brands that survived are already priced by the market.

The answer, today, is that it does not. The founder who built during the 1997 crisis, the dynasty that collapsed from succession failure, the palace princess who installed a professional CEO before she died, the trade association chairman who brews jamu like coffee — their stories are documented in Indonesian trade press, corporate registries, and court records. The intelligence has always been there. Scattered across publications that no institutional database indexes, in a language that no analyst platform reads, about an industry that UNESCO has certified as humanity’s heritage but that no investor report has mapped.

These brands have been here all along. Hiding in plain sight.

Last updated: April 5, 2026